1.0 2016-06-03 12:55:52 UTC 2026-05-14 18:24:57 UTC lanreotide SmallMolecule Lanreotide is an organic compound with the chemical formula C54H69N11O10S2. Lanreotide belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,096 g/mol, lanreotide is a heavy molecule. This compound is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically hypothalamic hormones. Its recorded route of exposure is subcutaneous. Lanreotide acts on two recorded protein targets, serving as an agonist of Somatostatin receptor type 2 (SSTR2) and Somatostatin receptor type 5 (SSTR5). C54H69N11O10S2 1096.33 1095.467029814 2-({19-[2-amino-3-(naphthalen-2-yl)propanamido]-10-(4-aminobutyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide 2-({19-[2-amino-3-(naphthalen-2-yl)propanamido]-10-(4-aminobutyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide 108736-35-2 [H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H] InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74) PUDHBTGHUJUUFI-UHFFFAOYSA-N Organic compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Acylaminobenzoic acid and derivatives 1,3-dicarbonyl compounds 2-halobenzoic acids and derivatives 4-halobenzoic acids and derivatives Anilides Aryl iodides Benzamides Benzoyl derivatives Hydrocarbon derivatives Iodobenzenes Organic oxides Organoiodides Organonitrogen compounds Organopnictogen compounds Polyols Primary alcohols Secondary alcohols Secondary carboxylic acid amides Tertiary carboxylic acid amides Vinylogous halides 1,3-dicarbonyl compound 2-halobenzoic acid or derivatives 4-halobenzoic acid or derivatives Acylaminobenzoic acid or derivatives Alcohol Anilide Aromatic homomonocyclic compound Aryl halide Aryl iodide Benzamide Benzoyl Carbonyl group Carboxamide group Carboxylic acid derivative Halobenzene Halobenzoic acid or derivatives Hydrocarbon derivative Iodobenzene Organic nitrogen compound Organic oxide Organic oxygen compound Organohalogen compound Organoiodide Organonitrogen compound Organooxygen compound Organopnictogen compound Polyol Primary alcohol Secondary alcohol Secondary carboxylic acid amide Tertiary carboxylic acid amide Vinylogous halide Aromatic homomonocyclic compounds Detected and Not Quantified Lanreotide Drug Metabolism Action Pathway SMP0144130 logp -0.33 logp 1.87 ALOGPS logs -5.34 ALOGPS solubility 4.96e-03 g/l ALOGPS logp -0.33 ChemAxon pka_strongest_acidic 9.43 ChemAxon pka_strongest_basic 10.26 ChemAxon iupac 2-({19-[2-amino-3-(naphthalen-2-yl)propanamido]-10-(4-aminobutyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide ChemAxon average_mass 1096.33 ChemAxon mono_mass 1095.467029814 ChemAxon smiles [H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H] ChemAxon formula C54H69N11O10S2 ChemAxon inchi InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74) ChemAxon inchikey PUDHBTGHUJUUFI-UHFFFAOYSA-N ChemAxon polar_surface_area 355.08 ChemAxon refractivity 292.92 ChemAxon polarizability 114.68 ChemAxon rotatable_bond_count 17 ChemAxon acceptor_count 12 ChemAxon donor_count 13 ChemAxon physiological_charge 2 ChemAxon formal_charge 0 ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f727b564b00> DB06791 71349 64450 BE0003528 BE0002147